Sociodemographic Factors Associated with Treatment for COVID-19 and Their Relationship with Short-Term Acute Care Utilization
Infusion Journal · 2023
DOI: 10.70776/baqc2995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infusion Journal, 2023. Verfasst von Kassie Klasen und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Health disparities have been exacerbated during the COVID-19 pandemic. Despite COVID-19 treatments being associated with lower morbidity and mortality, recent data illustrates that treatment may be underutilized by certain patient populations. This study examines patient sociodemographic and clinical characteristics and their relation to COVID-19 treatment, focusing on intravenous bebtelovimab, oral nirmatrelvir/ritonavir, or no treatment; data is extrapolated to further understand the relationship of treatment and patient characteristics on short-term acute care outcomes.
Methods
This was a retrospective cohort of patients who tested positive for COVID-19 between March and December 2022 and were considered at high-risk of severe COVID-19. Sociodemographic factors were compared across treatment groups: intravenous bebtelovimab, oral nirmatrelvir/ritonavir, or no treatment; logistic regression estimated the odds of receiving acute care in the 14 days following COVID-19 infection.
Results
There were 18,751 patients at high-risk for COVID-19; 12,688 patients (67.67%) received no treatment. Interpreter use, African American/Black race, and Medicaid insurance were associated with 1.7, 1.8, and 1.4 times less likelihood to receive treatment, respectively. Patients who did not receive treatment were 3.2 times more likely to utilize acute care compared to patients treated with bebtelovimab, after controlling for confounders.
Conclusion
Disparities in receiving COVID-19 treatment remain; since lack of treatment increases short-term health care utilization, health systems must find unique methodologies to improve access to care while preserving health care resources. Home infusion services, which supplied bebtelovimab within the health system, may be a leading strategy to increase health equity through improvement of access and education across many disease states beyond COVID-19 Keywords: COVID-19, oral antiviral, monoclonal antibody, social determinants of health
Zitieren
APA
Klasen, K., Zagel, A., Nelson, M., Betzold, E., & Benfield, B. (2023). Sociodemographic Factors Associated with Treatment for COVID-19 and Their Relationship with Short-Term Acute Care Utilization. Infusion Journal. https://doi.org/10.70776/baqc2995
Vancouver
Klasen K, Zagel A, Nelson M, Betzold E, Benfield B. Sociodemographic Factors Associated with Treatment for COVID-19 and Their Relationship with Short-Term Acute Care Utilization. Infusion Journal. 2023. doi:10.70776/baqc2995
BibTeX
@article{Klasen2023,
author = {Klasen, Kassie and Zagel, Alicia and Nelson, Mary and Betzold, Eric and Benfield, Brett},
title = {Sociodemographic Factors Associated with Treatment for COVID-19 and Their Relationship with Short-Term Acute Care Utilization},
journal = {Infusion Journal},
year = {2023},
doi = {10.70776/baqc2995}
}
EUVIMED